TQ Evening Briefing

Producer prices missed by a tenth, and the 10-year yield still touched 5.17%. Chip stocks fell as a group, and Modine rose 28% after a report of Samsung talks.

The Setup

The Miss Faded. The Core Stayed.

Producer prices rose 0.3% in October, a tenth of a point below forecasts. That was the good news, and it did not last.

The miss came from diesel and trade margins. Diesel fell 7.9%, and trade margins slipped 0.2%. Strip out food, energy and trade services, and prices rose 0.5% for a second straight month. Over 12 months, the headline index rose 6.5%, the most since November 2022.

Stocks opened higher after the release and then turned down. The S&P 500 closed down 0.4% and the Nasdaq 0.9%, while the Dow was little changed. The 10-year Treasury yield touched 5.17%, stayed above 5.1% all session and ended near 5.16%.

Friday's pattern was simple. Good news that left the rate path alone did not hold.

TQ Trade Implication

A softer headline gave stocks an early lift, and yields rose anyway. Core producer costs can pass into consumer prices with a lag, so a miss led by diesel and margins leaves that risk in place. That makes the headline a weak relief signal while the core runs at half a point a month. If the 10-year slips back below 5.1% before the core cools, Friday's selling was about positioning.

PREMIER FEATURE

The 7 Stocks Built to Outlast the Market

Some stocks are built for a quarter… others for a lifetime.

Our 7 Stocks to Buy and Hold Forever report reveals companies with the strength to deliver year after year - through recessions, rate hikes, and even the next crash.

One is a tech leader with a 15% payout ratio - leaving decades of room for dividend growth.

Another is a utility that’s paid every quarter for 96 years straight.

And that’s not all - we’ve included 5 more companies that treat payouts as high priority.

These are the stocks that anchor portfolios and keep paying.

This is your chance to see all 7 names and tickers - from a consumer staples powerhouse with 20 years of outperformance to a healthcare leader with 61 years of payout hikes.

The report is free for a limited time - go here to get it now.

Theme One

December Is Priced. January Is the Debate.

Futures fully price a December rate increase of at least a quarter point. Friday's debate was about what comes next.

Boston Fed President Susan Collins said "soon some additional firming" is appropriate. She added that a path a bit tighter than she had "penciled in" might fit. Chicago Fed President Austan Goolsbee said the Fed has "work to do" to rebuild its credibility. Neither votes this year. Goolsbee votes next year, when a January move would be decided.

One major dealer added a January hike to its forecast. Bank of America (BAC) economists now expect quarter-point increases in December, January and March. That would lift the funds rate to 4.5% to 4.75%, up from their earlier peak call of 4.25% to 4.5%. The current range is 3.75% to 4%.

TQ Edge Setup

The question has moved from whether the Fed hikes to how often. Back-to-back hikes pull the cost of short-term money forward, and borrowers feel that before inflation slows. That keeps the front of the curve in charge of the next few weeks. If next year's voters do not echo Collins's "soon," January stays a bank forecast instead of a market price.

Theme Two

Thursday's Chip Rotation Ran in Reverse

Thursday looked like a swap inside the sector. AMD (AMD) rose 5.9% that day while Nvidia (NVDA) fell after its chief executive resigned.

Friday undid it. AMD fell 8.8%, erasing Thursday's gain and more. The Philadelphia semiconductor index lost 3.4%.

Nvidia opened about 2% higher, then turned lower with the rest of the group. It closed down 2%, its sixth straight weekly loss.

When the leader and its rivals fall together, the selling points at the group as a whole. Nvidia reports results Tuesday, its first report under interim chief Colette Kress.

TQ Execution Bias

Friday's tape treated chipmakers as one trade again. Group-wide selling ties the discount to risks every chipmaker shares, such as AI spending and the cost of money. That tilts the read toward the sector as a single exposure and away from pairs inside it. If Nvidia's results Tuesday lift AMD along with it, the group is trading on its own business again.

FROM OUR PARTNERS

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)

"I want to give you a free stock pick today. This company's sales are up 28% year over year. It holds over 30,000 patents in wireless and video technology. And it just earned an A-rating in my proprietary Stock Grader system. That's the same system that helped me flag Nvidia back in 2005 — before its 82,000% run. In fact, this system has identified the top-performing S&P 500 stock for 12 years running. Over the years, it has cost me $9 million to build and maintain. And right now, it's flashing its highest possible rating on this AI play." — Louis Navellier Click here to see which AI stock my $9 million system is flagging right now, free.

This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.

Theme Three

Modine Jumped on Talks Nobody Has Confirmed

Samsung Electronics is in talks to buy Modine (MOD), a maker of data-center cooling systems, Bloomberg reported Thursday evening. The report cited people familiar with the matter and said the talks could still fall apart. Samsung said it could not confirm the report, and Modine declined to comment.

Modine opened at $142 and closed up 28%, at $135.66. Most peers fell, with Vertiv (VRT) down 3.6%.

The starting point matters. Modine closed at $125.45 on Nov. 3, hours before it reported results, and at $98.56 the next day. Measured from before the results, Friday's close is about 8% higher. Most of the jump only returns the stock toward its pre-results price.

Modine holds an investor day on Nov. 18 and plans to present new financial targets.

TQ Edge Setup

The stock now carries a premium for a deal with no reported price, terms or confirmation. Measured against the pre-results price, the takeover premium in the shares is thin. That makes the investor-day targets the bar any buyer would have to clear. If neither company confirms talks before the investor day, the price rests on Modine's own plan instead of a deal.

Quick Themes
  • The hike bet ran both ways. Kalshi's contract on a quarter-point December hike rose from 88 cents to 94 within minutes of the producer-price report. It slid to 86 cents in the early afternoon and last traded near 88. The contract pays only on exactly a quarter point. Selling it can mean bets on a bigger hike as easily as on no hike.
  • Bitcoin's bounce did not last. Bitcoin climbed back above $70,000 after the report, then slid back below $69,000. Fund selling was larger than first counted. Spot bitcoin funds lost about $284 million Thursday, not the $48 million early tallies showed. It was their sixth straight day of outflows.
  • A 19-year buyout ended without a price. Clayton, Dubilier & Rice sold lawn-care company TruGreen to Toronto's Birch Hill Equity Partners, TruGreen said. Terms were not disclosed. TruGreen had about $1.4 billion of term loans due in 2027 and 2028 as of this spring, according to credit research firm Octus. The announcement did not say how the new owner will handle that debt.
PARTNER SPOTLIGHT
The Close

The Rate Path Kept the Last Word

Friday tested good news against a 10-year yield that held above 5.1%. The producer-price miss, Nvidia's early gain and bitcoin's pop above $70,000 all faded. The gains that held came with company news attached, such as the reported takeover talks for Modine.

Nvidia's results Tuesday are the next real test. If the stock can hold a gain with the 10-year still above 5.1%, earnings can still outrun the rate path. If it fades like Friday's other relief, the rate path is setting prices for everything without company news behind it.

The Next AI Race Isn't About the Best Model.

Models improve. Computing gets cheaper. An algorithm can be matched.
What's hard to copy is a company's own lab data: experiments run at industrial scale, with every result fed back to make the AI smarter.
In drug development, that loop may become the edge that matters most. Not who has the best model. Who can learn biology fastest.
We profiled 5 companies building that loop in a new FREE Special Report: AI Moves Into the Biotech Lab.
We'll text it straight to your phone.

Get the Free Report by Text →